Vaccine value profile for invasive non-typhoidal Salmonella disease - Martin, Laura B.; Tack, Bieke; Marchello, Christian S.; Sikorski, Michael J.; Owusu-Dabo, Ellis; Nyirenda, Tonney; Mogasale, Vittal; Crump, John A. (Vaccine, 2024)
Keywords: Africa South of the Sahara - epidemiology; Allergy and Immunology; antibiotic resistance; Antimicrobial agents; Antimicrobial resistance; Bacteremia; Clinical trials; Combined vaccines; Comorbidity; Development strategies; Disease prevention; Drug resistance; Epidemiology; Fever; Genotypes; HIV; HIV infections; Human immunodeficiency virus; Humans; Illnesses; Infants; Infections; iNTS; Invasive non-typhoidal Salmonella; Malaria; Malnutrition; Meningitis; Nonprofit organizations; Organizations; Pathogens; Population-based studies; Public health; Public private partnerships; Quality control; R&D; Research & development; research and development; Risk factors; Salmonella; Salmonella Enteritidis; Salmonella enteritidis - genetics; Salmonella enteritidis - immunology; Salmonella enteritidis - pathogenicity; Salmonella Infections - epidemiology; Salmonella Infections - immunology; Salmonella Infections - microbiology; Salmonella Infections - prevention & control; Salmonella Typhi; Salmonella Typhimurium; Salmonella typhimurium - genetics; Salmonella typhimurium - immunology; Salmonella typhimurium - pathogenicity; Salmonella Vaccines - administration & dosage; Salmonella Vaccines - immunology; serotypes; social benefit; stakeholders; Sub-Saharan Africa; Surveillance; therapeutics; Tropical diseases; Typhoid; Vaccine; Vaccine development; Vaccine value profile; Vaccines; Virulence; World Health Organization; Africa South of the Sahara; Zambia; Nigeria; Kenya; Africa; Sub-Saharan Africa; sSA; VIS; AVAREF; PDVAC; SAGE; NARMS; DT; VVP; QC; FERG; TSCV; Pf; WaSH; Tfh; SETA; UN; MDR; Th17; CMI; WHO; IL; IM; AMR; MIC; GMP; IV